These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19758190)

  • 1. Preventing viral-induced type 1 diabetes.
    Richer MJ; Horwitz MS
    Ann N Y Acad Sci; 2009 Sep; 1173():487-92. PubMed ID: 19758190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD3-specific antibodies: a portal to the treatment of autoimmunity.
    Chatenoud L; Bluestone JA
    Nat Rev Immunol; 2007 Aug; 7(8):622-32. PubMed ID: 17641665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific induction of regulatory T cells for type 1 diabetes therapy.
    Filippi C; Bresson D; von Herrath M
    Int Rev Immunol; 2005; 24(5-6):341-60. PubMed ID: 16318986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T-cell physiology and application to treat autoimmunity.
    Tang Q; Bluestone JA
    Immunol Rev; 2006 Aug; 212():217-37. PubMed ID: 16903917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CD3-specific antibody-induced T-cell apoptosis and apoptotic cell uptake lead to CD3-specific antibody-induced tolerance].
    Perruche S; Saas P
    Med Sci (Paris); 2009 Apr; 25(4):325-7. PubMed ID: 19409176
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of viruses in type I diabetes.
    von Herrath MG; Holz A; Homann D; Oldstone MB
    Semin Immunol; 1998 Feb; 10(1):87-100. PubMed ID: 9529659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it dietary insulin?
    Vaarala O
    Ann N Y Acad Sci; 2006 Oct; 1079():350-9. PubMed ID: 17130578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a cocktail regimen consisting of soluble galectin-1, rapamycin and histone deacetylase inhibitor may effectively prevent type 1 diabetes.
    Jiang GX; Cui YF; Zhong XY; Tai S; Liu W; Wang ZD; Shi YG
    Arch Med Res; 2009 Jul; 40(5):424-6. PubMed ID: 19766909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of regulatory T cells in chronic and acute viral infections.
    Keynan Y; Card CM; McLaren PJ; Dawood MR; Kasper K; Fowke KR
    Clin Infect Dis; 2008 Apr; 46(7):1046-52. PubMed ID: 18444822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
    Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
    Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is activation of autoreactive lymphocytes always detrimental? Viral infections and regulatory circuits in autoimmunity.
    von Herrath MG; Oldstone M; Homann D; Christen U
    Curr Dir Autoimmun; 2001; 4():91-122. PubMed ID: 11569412
    [No Abstract]   [Full Text] [Related]  

  • 12. Viral trigger for type 1 diabetes: pros and cons.
    Filippi CM; von Herrath MG
    Diabetes; 2008 Nov; 57(11):2863-71. PubMed ID: 18971433
    [No Abstract]   [Full Text] [Related]  

  • 13. How viral infections affect the autoimmune process leading to type 1 diabetes.
    Filippi C; von Herrath M
    Cell Immunol; 2005 Feb; 233(2):125-32. PubMed ID: 15963965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology. Policing the immune system.
    Wickelgren I
    Science; 2004 Oct; 306(5696):596-9. PubMed ID: 15498987
    [No Abstract]   [Full Text] [Related]  

  • 15. [Do the regulatory T cells play a role in the pathogenesis and therapy of type 1 diabetes?].
    Luczyński W; Urban R; Stasiak-Barmuta A; Urban M
    Pediatr Endocrinol Diabetes Metab; 2009; 15(1):41-4. PubMed ID: 19454188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies.
    Ejrnaes M; von Herrath MG; Christen U
    Clin Dev Immunol; 2006; 13(2-4):337-47. PubMed ID: 17162375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to diabetes disease control, insulin delivery, and monitoring.
    McCarthy AA
    Chem Biol; 2004 Dec; 11(12):1597-8. PubMed ID: 15610839
    [No Abstract]   [Full Text] [Related]  

  • 18. CD3 antibodies as unique tools to restore self-tolerance in established autoimmunity their mode of action and clinical application in type 1 diabetes.
    You S; Candon S; Kuhn C; Bach JF; Chatenoud L
    Adv Immunol; 2008; 100():13-37. PubMed ID: 19111162
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppressor T cells--they're back and critical for regulation of autoimmunity!
    Chatenoud L; Salomon B; Bluestone JA
    Immunol Rev; 2001 Aug; 182():149-63. PubMed ID: 11722631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of CD3-specific antibodies in autoimmune diabetes: a step toward the induction of immune tolerance in the clinic.
    Chatenoud L
    Handb Exp Pharmacol; 2008; (181):221-36. PubMed ID: 18071948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.